SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3PE'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A4L_C_DCFC1353_2 (ADENOSINE DEAMINASE)	6g2j	NADH DEHYDROGENASE [UBIQUINONE] 1 BETA SUBCOMPLEX SUBUNIT 11, MITOCHONDRIAL NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 5	LEU M 36 LEU M 39 LEU M 453 GLY g 71	3PE M 504 (-4.2A) None 3PE M 503 ( 4.2A) None	0.97A	1a4lC-6g2jM: undetectable	1a4lC-6g2jM: 12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A4L_D_DCFD1853_1 (ADENOSINE DEAMINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 12	ALA A 310 GLY A 309 HIS A 321 HIS A 253 ASP A 189	3PE A 503 ( 4.7A) None 3PE A 503 (-3.8A) ZN A 501 ( 3.5A) ZN A 502 ( 2.5A)	1.10A	1a4lD-4qn9A: 2.3	1a4lD-4qn9A: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 8	HIS A 343 GLY A 131 GLY A 345 LEU A 349	ZN A 502 ( 3.6A) None None 3PE A 503 ( 4.6A)	0.73A	1aegA-4qn9A: undetectable	1aegA-4qn9A: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AZM_A_AZMA262_1 (CARBONIC ANHYDRASE I)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 8	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 321	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) 3PE A 503 (-3.8A)	1.49A	1azmA-4qn9A: undetectable	1azmA-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AZM_A_AZMA262_1 (CARBONIC ANHYDRASE I)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 8	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 343	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) ZN A 502 ( 3.6A)	1.44A	1azmA-4qn9A: undetectable	1azmA-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GMK_A_DVAA8_0 (GRAMICIDIN A)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	3 / 4	VAL M 27 TRP M 16 TRP M 24	None 3PE M 505 ( 4.3A) None	1.39A	1gmkA-6g2jM: undetectable 1gmkB-6g2jM: undetectable	1gmkA-6g2jM: undetectable 1gmkB-6g2jM: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JFF_B_TA1B601_1 (TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.18A	1jffB-6g2jM: undetectable	1jffB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JHR_A_NIOA991_1 (NICOTINATE MONONUCLEOTIDE:5,6-D IMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.30A	1jhrA-6g2jL: undetectable	1jhrA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JHY_A_NIOA991_1 (NICOTINATE MONONUCLEOTIDE:5,6-D IMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.32A	1jhyA-6g2jL: undetectable	1jhyA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L4N_A_NIOA991_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.29A	1l4nA-6g2jL: undetectable	1l4nA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5K_A_NIOA991_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.27A	1l5kA-6g2jL: undetectable	1l5kA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5M_A_NIOA991_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.28A	1l5mA-6g2jL: undetectable	1l5mA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QVT_A_PRLA311_0 (TRANSCRIPTIONAL REGULATOR QACR)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus; Mus musculus)	4 / 8	LEU L 558 THR M 153 TYR M 152 ILE L 562	None None 3PE M 501 ( 4.4A) 3PE M 501 (-4.0A)	1.11A	1qvtA-6g2jL: undetectable	1qvtA-6g2jL: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WMQ_A_HISA2001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.91A	1wmqA-5ej1A: undetectable	1wmqA-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WMQ_B_HISB1001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.92A	1wmqB-5ej1A: undetectable	1wmqB-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WPU_A_HISA2001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.91A	1wpuA-5ej1A: undetectable	1wpuA-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WPU_B_HISB1001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.91A	1wpuB-5ej1A: 2.5	1wpuB-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRQ_A_HISA2001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.91A	1wrqA-5ej1A: undetectable	1wrqA-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRQ_B_HISB1001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	5ej1	PUTATIVE CELLULOSE SYNTHASE (Rhodobacter sphaeroides)	4 / 6	ARG A 705 ILE A 707 GLY A 712 ALA A 714	None None None 3PE A 923 ( 4.4A)	0.93A	1wrqB-5ej1A: undetectable	1wrqB-5ej1A: 12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_F_SPMF1433_1 (NITROALKANE OXIDASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 11	GLN M 103 LEU M 77 LEU M 12 SER M 97 LEU M 99	None None 3PE M 505 ( 4.9A) 3PE M 505 (-3.4A) None	1.29A	2c12F-6g2jM: undetectable	2c12F-6g2jM: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXF_B_TA1B601_1 (TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.19A	2hxfB-6g2jM: undetectable	2hxfB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXH_B_TA1B601_1 (TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.19A	2hxhB-6g2jM: undetectable	2hxhB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J9C_C_ACTC1120_0 (HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus; Mus musculus)	3 / 3	LYS L 564 TYR M 148 PRO L 563	3PE M 501 (-2.5A) 3PE M 501 ( 4.9A) 3PE M 501 ( 4.6A)	1.46A	2j9cC-6g2jL: undetectable	2j9cC-6g2jL: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P4N_B_TA1B601_1 (TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.18A	2p4nB-6g2jM: undetectable	2p4nB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WBE_B_TA1B1439_1 (TUBULIN BETA-2B CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.19A	2wbeB-6g2jM: undetectable	2wbeB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOY_A_HISA1001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 10	GLY A 283 ALA A 282 HIS A 185 HIS A 253 HIS A 321	None None ZN A 501 (-3.6A) ZN A 501 ( 3.5A) 3PE A 503 (-3.8A)	1.02A	3boyA-4qn9A: undetectable 3boyC-4qn9A: undetectable	3boyA-4qn9A: 16.71 3boyC-4qn9A: 16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOY_A_HISA2001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 10	HIS A 253 HIS A 321 GLY A 283 ALA A 282 HIS A 185	ZN A 501 ( 3.5A) 3PE A 503 (-3.8A) None None ZN A 501 (-3.6A)	1.01A	3boyA-4qn9A: undetectable 3boyB-4qn9A: undetectable	3boyA-4qn9A: 16.71 3boyB-4qn9A: 16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOY_A_HISA3001_0 (HUT OPERON POSITIVE REGULATORY PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 10	HIS A 253 HIS A 321 GLY A 283 ALA A 282 HIS A 185	ZN A 501 ( 3.5A) 3PE A 503 (-3.8A) None None ZN A 501 (-3.6A)	1.02A	3boyB-4qn9A: undetectable 3boyC-4qn9A: undetectable	3boyB-4qn9A: 16.71 3boyC-4qn9A: 16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DCO_B_TA1B601_1 (BOVINE BETA TUBULIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.18A	3dcoB-6g2jM: undetectable	3dcoB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EDL_B_TA1B601_1 (BETA TUBULIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.18A	3edlB-6g2jM: undetectable	3edlB-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IZ0_B_TA1B820_1 (BETA TUBULIN, CHAIN B FROM PDB 1JFF)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	VAL M 297 LEU M 321 SER M 240 LEU M 68 GLY M 456	None None None 3PE M 503 ( 4.2A) None	1.15A	3iz0B-6g2jM: undetectable	3iz0B-6g2jM: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JUS_A_ECLA600_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 8	LEU M 360 THR M 357 ALA M 438 ILE M 445	None CDL L 702 (-4.1A) None 3PE M 503 (-4.2A)	0.77A	3jusA-6g2jM: undetectable	3jusA-6g2jM: 13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JUS_A_ECNA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 8	LEU M 360 THR M 357 ALA M 438 ILE M 445	None CDL L 702 (-4.1A) None 3PE M 503 (-4.2A)	0.77A	3jusA-6g2jM: undetectable	3jusA-6g2jM: 13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP2_A_PNNA5001_0 (TRANSCRIPTIONAL REGULATOR TCAR)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 8	ASN M 366 THR M 322 LEU M 444 SER M 372	None None None 3PE M 503 ( 4.3A)	1.16A	3kp2A-6g2jM: undetectable 3kp2B-6g2jM: undetectable	3kp2A-6g2jM: undetectable 3kp2B-6g2jM: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXE_A_TORA262_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 12	HIS A 185 PHE A 316 GLN A 320 HIS A 321 HIS A 343	ZN A 501 (-3.6A) None 3PE A 503 (-4.1A) 3PE A 503 (-3.8A) ZN A 502 ( 3.6A)	1.14A	3lxeA-4qn9A: undetectable	3lxeA-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXE_B_TORB262_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 12	HIS A 185 PHE A 316 GLN A 320 HIS A 321 HIS A 343	ZN A 501 (-3.6A) None 3PE A 503 (-4.1A) 3PE A 503 (-3.8A) ZN A 502 ( 3.6A)	1.13A	3lxeB-4qn9A: undetectable	3lxeB-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_B_SUEB1201_3 (NS3 PROTEASE, NS4A PROTEIN)	6g2j	NADH DEHYDROGENASE [UBIQUINONE] 1 ALPHA SUBCOMPLEX SUBUNIT 10, MITOCHONDRIAL NADH DEHYDROGENASE [UBIQUINONE] 1 SUBUNIT C2 (Mus musculus)	4 / 5	ARG d 51 PRO d 52 TYR O 308 VAL d 53	None None None 3PE M 506 (-4.3A)	1.33A	3sufC-6g2jd: undetectable	3sufC-6g2jd: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUG_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 12	HIS A 343 GLY A 309 ASP A 284 ARG A 257 ALA A 154	ZN A 502 ( 3.6A) None ZN A 502 (-2.5A) None 3PE A 503 (-4.7A)	1.04A	3sugA-4qn9A: undetectable	3sugA-4qn9A: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W6H_A_AZMA303_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 8	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 321	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) 3PE A 503 (-3.8A)	1.49A	3w6hA-4qn9A: undetectable	3w6hA-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W6H_A_AZMA303_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 8	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 343	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) ZN A 502 ( 3.6A)	1.43A	3w6hA-4qn9A: undetectable	3w6hA-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W6H_B_AZMB303_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 9	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 321	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) 3PE A 503 (-3.8A)	1.49A	3w6hB-4qn9A: undetectable	3w6hB-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W6H_B_AZMB303_1 (CARBONIC ANHYDRASE 1)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 9	HIS A 185 HIS A 253 HIS A 187 LEU A 349 HIS A 343	ZN A 501 (-3.6A) ZN A 501 ( 3.5A) ZN A 501 ( 3.4A) 3PE A 503 ( 4.6A) ZN A 502 ( 3.6A)	1.43A	3w6hB-4qn9A: undetectable	3w6hB-4qn9A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KQI_A_NIOA403_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 9	THR L 221 GLY L 228 GLY L 311 SER L 307 GLY L 281	None 3PE L 701 (-3.9A) None None None	1.34A	4kqiA-6g2jL: undetectable	4kqiA-6g2jL: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_A_ADNA401_2 (ADENOSINE KINASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 4	LEU M 106 SER M 101 LEU M 73 LEU M 235	None 3PE M 505 ( 3.8A) None None	0.88A	4n09A-6g2jM: undetectable	4n09A-6g2jM: 11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_B_ADNB401_2 (ADENOSINE KINASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 5	LEU M 106 SER M 101 LEU M 73 LEU M 235	None 3PE M 505 ( 3.8A) None None	0.86A	4n09B-6g2jM: undetectable	4n09B-6g2jM: 11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_D_ADND401_2 (ADENOSINE KINASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 5	LEU M 106 SER M 101 LEU M 73 LEU M 235	None 3PE M 505 ( 3.8A) None None	0.88A	4n09D-6g2jM: undetectable	4n09D-6g2jM: 11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6S_A_DAHA305_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 253 HIS A 190 HIS A 343 ALA A 310	ZN A 501 ( 3.5A) ZN A 502 (-3.5A) ZN A 502 ( 3.6A) 3PE A 503 ( 4.7A)	0.70A	4p6sA-4qn9A: undetectable	4p6sA-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6S_A_DAHA305_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 343 HIS A 190 HIS A 253 ALA A 310	ZN A 502 ( 3.6A) ZN A 502 (-3.5A) ZN A 501 ( 3.5A) 3PE A 503 ( 4.7A)	0.93A	4p6sA-4qn9A: undetectable	4p6sA-4qn9A: 22.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QN9_B_DXCB601_0 (N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 5	TYR A 188 TRP A 218 ARG A 257 THR A 258	3PE A 503 ( 4.9A) DXC A 504 ( 3.9A) None DXC A 507 (-3.7A)	0.12A	4qn9A-4qn9A: 61.9 4qn9B-4qn9A: 60.5	4qn9A-4qn9A: 100.00 4qn9B-4qn9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QN9_B_DXCB610_0 (N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	3 / 3	GLY A 161 PRO A 162 ALA A 348	3PE A 503 ( 4.5A) 3PE A 503 ( 4.7A) None	0.07A	4qn9B-4qn9A: 60.5	4qn9B-4qn9A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UDA_A_DEXA1985_1 (MINERALOCORTICOID RECEPTOR)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	LEU M 68 ALA M 232 MET M 294 SER M 290 LEU M 315	3PE M 503 ( 4.2A) None None None None	1.46A	4udaA-6g2jM: undetectable	4udaA-6g2jM: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1K_B_LOCB502_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	CYH M 199 LEU M 160 LEU M 195 ALA M 163 THR M 182	None None 3PE M 502 ( 4.1A) 3PE M 502 ( 4.3A) None	0.97A	4x1kA-6g2jM: undetectable 4x1kB-6g2jM: undetectable	4x1kA-6g2jM: 10.93 4x1kB-6g2jM: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1Y_B_LOCB502_1 (TUBULIN BETA CHAIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	5 / 12	CYH M 199 LEU M 160 LEU M 195 ALA M 163 THR M 182	None None 3PE M 502 ( 4.1A) 3PE M 502 ( 4.3A) None	1.10A	4x1yB-6g2jM: undetectable	4x1yB-6g2jM: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B8I_C_FK5C201_1 (SERINE/THREONINE-PRO TEIN PHOSPHATASE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 6	LEU M 457 SER M 62 PRO M 64 PHE M 110	None None 3PE M 503 ( 4.6A) None	1.14A	5b8iA-6g2jM: undetectable	5b8iA-6g2jM: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D4U_A_SAMA301_0 (UNCHARACTERIZED PROTEIN MJ0489)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5 (Mus musculus)	5 / 12	LEU L 216 MET L 314 LEU L 283 GLY L 228 GLY L 181	None None None 3PE L 701 (-3.9A) None	1.14A	5d4uA-6g2jL: undetectable	5d4uA-6g2jL: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3A_A_HQEA303_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 253 HIS A 190 HIS A 343 ALA A 310	ZN A 501 ( 3.5A) ZN A 502 (-3.5A) ZN A 502 ( 3.6A) 3PE A 503 ( 4.7A)	0.73A	5i3aA-4qn9A: undetectable	5i3aA-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3A_A_HQEA303_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 343 HIS A 190 HIS A 253 ALA A 310	ZN A 502 ( 3.6A) ZN A 502 (-3.5A) ZN A 501 ( 3.5A) 3PE A 503 ( 4.7A)	0.88A	5i3aA-4qn9A: undetectable	5i3aA-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3A_B_HQEB304_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 253 HIS A 190 HIS A 343 ALA A 310	ZN A 501 ( 3.5A) ZN A 502 (-3.5A) ZN A 502 ( 3.6A) 3PE A 503 ( 4.7A)	0.73A	5i3aB-4qn9A: undetectable	5i3aB-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3A_B_HQEB304_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 343 HIS A 190 HIS A 253 ALA A 310	ZN A 502 ( 3.6A) ZN A 502 (-3.5A) ZN A 501 ( 3.5A) 3PE A 503 ( 4.7A)	0.86A	5i3aB-4qn9A: undetectable	5i3aB-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3B_A_HQEA303_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 253 HIS A 190 HIS A 343 ALA A 310	ZN A 501 ( 3.5A) ZN A 502 (-3.5A) ZN A 502 ( 3.6A) 3PE A 503 ( 4.7A)	0.73A	5i3bA-4qn9A: undetectable	5i3bA-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3B_A_HQEA303_1 (TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 7	HIS A 343 HIS A 190 HIS A 253 ALA A 310	ZN A 502 ( 3.6A) ZN A 502 (-3.5A) ZN A 501 ( 3.5A) 3PE A 503 ( 4.7A)	0.87A	5i3bA-4qn9A: undetectable	5i3bA-4qn9A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NCD_D_ACTD301_0 (PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 4	ASP A 284 HIS A 190 HIS A 132 HIS A 321	ZN A 502 (-2.5A) ZN A 502 (-3.5A) None 3PE A 503 (-3.8A)	1.31A	5ncdD-4qn9A: undetectable	5ncdD-4qn9A: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NEK_D_AZMD302_1 (PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 8	ASP A 284 HIS A 343 HIS A 321 HIS A 185	ZN A 502 (-2.5A) ZN A 502 ( 3.6A) 3PE A 503 (-3.8A) ZN A 501 (-3.6A)	0.91A	5nekD-4qn9A: undetectable	5nekD-4qn9A: 12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	6 / 10	HIS A 185 HIS A 187 HIS A 190 HIS A 253 ASP A 284 HIS A 321	ZN A 501 (-3.6A) ZN A 501 ( 3.4A) ZN A 502 (-3.5A) ZN A 501 ( 3.5A) ZN A 502 (-2.5A) 3PE A 503 (-3.8A)	0.34A	5nzwA-4qn9A: 12.2	5nzwA-4qn9A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 10	HIS A 253 HIS A 185 HIS A 321 ASP A 284 HIS A 343	ZN A 501 ( 3.5A) ZN A 501 (-3.6A) 3PE A 503 (-3.8A) ZN A 502 (-2.5A) ZN A 502 ( 3.6A)	1.02A	5nzwA-4qn9A: 12.2	5nzwA-4qn9A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z0F_B_DAHB98_0 (MELC TYROSINASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	5 / 11	HIS A 190 HIS A 132 HIS A 321 ASP A 323 PRO A 324	ZN A 502 (-3.5A) None 3PE A 503 (-3.8A) None None	1.29A	5z0fA-4qn9A: undetectable 5z0fB-4qn9A: undetectable	5z0fA-4qn9A: 13.05 5z0fB-4qn9A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWD_B_GLYB709_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	5lnk	MITOCHONDRIAL COMPLEX I, B14.5B SUBUNIT (Ovis aries)	4 / 5	GLY o 42 ASN o 46 ASP o 45 ARG o 60	None None None 3PE o 203 (-3.3A)	1.40A	6dwdB-5lnko: undetectable 6dwdD-5lnko: undetectable	6dwdB-5lnko: 13.13 6dwdD-5lnko: 13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWJ_B_GLYB710_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	5lnk	MITOCHONDRIAL COMPLEX I, B14.5B SUBUNIT (Ovis aries)	4 / 5	ARG o 60 GLY o 42 ASN o 46 ASP o 45	3PE o 203 (-3.3A) None None None	1.26A	6dwjB-5lnko: undetectable 6dwjD-5lnko: undetectable	6dwjB-5lnko: 13.13 6dwjD-5lnko: 13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MVX_A_K4DA1304_0 (ION TRANSPORT PROTEIN)	6g2j	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (Mus musculus)	4 / 6	THR M 69 LEU M 68 MET M 76 LEU M 39	None 3PE M 503 ( 4.2A) None None	1.05A	6mvxA-6g2jM: undetectable 6mvxB-6g2jM: undetectable 6mvxC-6g2jM: undetectable	6mvxA-6g2jM: undetectable 6mvxB-6g2jM: undetectable 6mvxC-6g2jM: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A4L_C_DCFC1353_2","ADENOSINE DEAMINASE","6g2j","NADH DEHYDROGENASE [UBIQUINONE] 1 BETA SUBCOMPLEX SUBUNIT 11, MITOCHONDRIAL;NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M  36;LEU M  39;LEU M 453;GLY g  71","3PE M 504 (-4.2A);None;3PE M 503 ( 4.2A);None","0.97A","1a4lC-6g2jM:undetectable",null],["1A4L_D_DCFD1853_1","ADENOSINE DEAMINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"ALA A 310;GLY A 309;HIS A 321;HIS A 253;ASP A 189","3PE A 503 ( 4.7A);None;3PE A 503 (-3.8A); ZN A 501 ( 3.5A); ZN A 502 ( 2.5A)","1.10A","1a4lD-4qn9A:2.3","1a4lC-6g2jM:12.03"],["1AEG_A_4APA296_1","CYTOCHROME C PEROXIDASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 343;GLY A 131;GLY A 345;LEU A 349"," ZN A 502 ( 3.6A);None;None;3PE A 503 ( 4.6A)","0.73A","1aegA-4qn9A:undetectable","1a4lD-4qn9A:21.18"],["1AZM_A_AZMA262_1","CARBONIC ANHYDRASE I","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 321"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A);3PE A 503 (-3.8A)","1.49A","1azmA-4qn9A:undetectable","1aegA-4qn9A:21.61"],["1AZM_A_AZMA262_1","CARBONIC ANHYDRASE I","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 343"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A); ZN A 502 ( 3.6A)","1.44A","1azmA-4qn9A:undetectable","1azmA-4qn9A:20.50"],["1GMK_A_DVAA8_0","GRAMICIDIN A","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",3,"VAL M  27;TRP M  16;TRP M  24","None;3PE M 505 ( 4.3A);None","1.39A","1gmkA-6g2jM:undetectable;1gmkB-6g2jM:undetectable","1azmA-4qn9A:20.50"],["1JFF_B_TA1B601_1","TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.18A","1jffB-6g2jM:undetectable","1gmkA-6g2jM:undetectable;1gmkB-6g2jM:undetectable"],["1JHR_A_NIOA991_1","NICOTINATE MONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.30A","1jhrA-6g2jL:undetectable","1jffB-6g2jM:11.26"],["1JHY_A_NIOA991_1","NICOTINATE MONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.32A","1jhyA-6g2jL:undetectable","1jhrA-6g2jL:10.14"],["1L4N_A_NIOA991_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.29A","1l4nA-6g2jL:undetectable","1jhyA-6g2jL:10.14"],["1L5K_A_NIOA991_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.27A","1l5kA-6g2jL:undetectable","1l4nA-6g2jL:10.14"],["1L5M_A_NIOA991_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.28A","1l5mA-6g2jL:undetectable","1l5kA-6g2jL:10.14"],["1QVT_A_PRLA311_0","TRANSCRIPTIONAL REGULATOR QACR","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5;NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus;Mus musculus",4,"LEU L 558;THR M 153;TYR M 152;ILE L 562","None;None;3PE M 501 ( 4.4A);3PE M 501 (-4.0A)","1.11A","1qvtA-6g2jL:undetectable","1l5mA-6g2jL:10.14"],["1WMQ_A_HISA2001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.91A","1wmqA-5ej1A:undetectable","1qvtA-6g2jL:undetectable"],["1WMQ_B_HISB1001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.92A","1wmqB-5ej1A:undetectable","1wmqA-5ej1A:12.22"],["1WPU_A_HISA2001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.91A","1wpuA-5ej1A:undetectable","1wmqB-5ej1A:12.22"],["1WPU_B_HISB1001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.91A","1wpuB-5ej1A:2.5","1wpuA-5ej1A:12.22"],["1WRQ_A_HISA2001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.91A","1wrqA-5ej1A:undetectable","1wpuB-5ej1A:12.22"],["1WRQ_B_HISB1001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","5ej1","PUTATIVE CELLULOSE SYNTHASE","Rhodobacter sphaeroides",4,"ARG A 705;ILE A 707;GLY A 712;ALA A 714","None;None;None;3PE A 923 ( 4.4A)","0.93A","1wrqB-5ej1A:undetectable","1wrqA-5ej1A:12.22"],["2C12_F_SPMF1433_1","NITROALKANE OXIDASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"GLN M 103;LEU M  77;LEU M  12;SER M  97;LEU M  99","None;None;3PE M 505 ( 4.9A);3PE M 505 (-3.4A);None","1.29A","2c12F-6g2jM:undetectable","1wrqB-5ej1A:12.22"],["2HXF_B_TA1B601_1","TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.19A","2hxfB-6g2jM:undetectable","2c12F-6g2jM:12.30"],["2HXH_B_TA1B601_1","TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.19A","2hxhB-6g2jM:undetectable","2hxfB-6g2jM:11.26"],["2J9C_C_ACTC1120_0","HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5;NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus;Mus musculus",3,"LYS L 564;TYR M 148;PRO L 563","3PE M 501 (-2.5A);3PE M 501 ( 4.9A);3PE M 501 ( 4.6A)","1.46A","2j9cC-6g2jL:undetectable","2hxhB-6g2jM:11.26"],["2P4N_B_TA1B601_1","TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.18A","2p4nB-6g2jM:undetectable","2j9cC-6g2jL:undetectable"],["2WBE_B_TA1B1439_1","TUBULIN BETA-2B CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.19A","2wbeB-6g2jM:undetectable","2p4nB-6g2jM:11.26"],["3BOY_A_HISA1001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"GLY A 283;ALA A 282;HIS A 185;HIS A 253;HIS A 321","None;None; ZN A 501 (-3.6A); ZN A 501 ( 3.5A);3PE A 503 (-3.8A)","1.02A","3boyA-4qn9A:undetectable;3boyC-4qn9A:undetectable","2wbeB-6g2jM:11.26"],["3BOY_A_HISA2001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 253;HIS A 321;GLY A 283;ALA A 282;HIS A 185"," ZN A 501 ( 3.5A);3PE A 503 (-3.8A);None;None; ZN A 501 (-3.6A)","1.01A","3boyA-4qn9A:undetectable;3boyB-4qn9A:undetectable","3boyA-4qn9A:16.71;3boyC-4qn9A:16.71"],["3BOY_A_HISA3001_0","HUT OPERON POSITIVE REGULATORY PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 253;HIS A 321;GLY A 283;ALA A 282;HIS A 185"," ZN A 501 ( 3.5A);3PE A 503 (-3.8A);None;None; ZN A 501 (-3.6A)","1.02A","3boyB-4qn9A:undetectable;3boyC-4qn9A:undetectable","3boyA-4qn9A:16.71;3boyB-4qn9A:16.71"],["3DCO_B_TA1B601_1","BOVINE BETA TUBULIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.18A","3dcoB-6g2jM:undetectable","3boyB-4qn9A:16.71;3boyC-4qn9A:16.71"],["3EDL_B_TA1B601_1","BETA TUBULIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.18A","3edlB-6g2jM:undetectable","3dcoB-6g2jM:11.26"],["3IZ0_B_TA1B820_1","BETA TUBULIN, CHAIN B FROM PDB 1JFF","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"VAL M 297;LEU M 321;SER M 240;LEU M  68;GLY M 456","None;None;None;3PE M 503 ( 4.2A);None","1.15A","3iz0B-6g2jM:undetectable","3edlB-6g2jM:11.26"],["3JUS_A_ECLA600_1","LANOSTEROL 14-ALPHA DEMETHYLASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 360;THR M 357;ALA M 438;ILE M 445","None;CDL L 702 (-4.1A);None;3PE M 503 (-4.2A)","0.77A","3jusA-6g2jM:undetectable","3iz0B-6g2jM:11.26"],["3JUS_A_ECNA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 360;THR M 357;ALA M 438;ILE M 445","None;CDL L 702 (-4.1A);None;3PE M 503 (-4.2A)","0.77A","3jusA-6g2jM:undetectable","3jusA-6g2jM:13.20"],["3KP2_A_PNNA5001_0","TRANSCRIPTIONAL REGULATOR TCAR","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"ASN M 366;THR M 322;LEU M 444;SER M 372","None;None;None;3PE M 503 ( 4.3A)","1.16A","3kp2A-6g2jM:undetectable;3kp2B-6g2jM:undetectable","3jusA-6g2jM:13.20"],["3LXE_A_TORA262_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;PHE A 316;GLN A 320;HIS A 321;HIS A 343"," ZN A 501 (-3.6A);None;3PE A 503 (-4.1A);3PE A 503 (-3.8A); ZN A 502 ( 3.6A)","1.14A","3lxeA-4qn9A:undetectable","3kp2A-6g2jM:undetectable;3kp2B-6g2jM:undetectable"],["3LXE_B_TORB262_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;PHE A 316;GLN A 320;HIS A 321;HIS A 343"," ZN A 501 (-3.6A);None;3PE A 503 (-4.1A);3PE A 503 (-3.8A); ZN A 502 ( 3.6A)","1.13A","3lxeB-4qn9A:undetectable","3lxeA-4qn9A:20.50"],["3SUF_B_SUEB1201_3","NS3 PROTEASE, NS4A PROTEIN;NS3 PROTEASE, NS4A PROTEIN","6g2j","NADH DEHYDROGENASE [UBIQUINONE] 1 ALPHA SUBCOMPLEX SUBUNIT 10, MITOCHONDRIAL;NADH DEHYDROGENASE [UBIQUINONE] 1 SUBUNIT C2","Mus musculus",4,"ARG d  51;PRO d  52;TYR O 308;VAL d  53","None;None;None;3PE M 506 (-4.3A)","1.33A","3sufC-6g2jd:undetectable","3lxeB-4qn9A:20.50"],["3SUG_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 343;GLY A 309;ASP A 284;ARG A 257;ALA A 154"," ZN A 502 ( 3.6A);None; ZN A 502 (-2.5A);None;3PE A 503 (-4.7A)","1.04A","3sugA-4qn9A:undetectable","3sufC-6g2jd:20.00"],["3W6H_A_AZMA303_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 321"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A);3PE A 503 (-3.8A)","1.49A","3w6hA-4qn9A:undetectable","3sugA-4qn9A:17.82"],["3W6H_A_AZMA303_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 343"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A); ZN A 502 ( 3.6A)","1.43A","3w6hA-4qn9A:undetectable","3w6hA-4qn9A:20.50"],["3W6H_B_AZMB303_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 321"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A);3PE A 503 (-3.8A)","1.49A","3w6hB-4qn9A:undetectable","3w6hA-4qn9A:20.50"],["3W6H_B_AZMB303_1","CARBONIC ANHYDRASE 1","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 185;HIS A 253;HIS A 187;LEU A 349;HIS A 343"," ZN A 501 (-3.6A); ZN A 501 ( 3.5A); ZN A 501 ( 3.4A);3PE A 503 ( 4.6A); ZN A 502 ( 3.6A)","1.43A","3w6hB-4qn9A:undetectable","3w6hB-4qn9A:20.50"],["4KQI_A_NIOA403_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"THR L 221;GLY L 228;GLY L 311;SER L 307;GLY L 281","None;3PE L 701 (-3.9A);None;None;None","1.34A","4kqiA-6g2jL:undetectable","3w6hB-4qn9A:20.50"],["4N09_A_ADNA401_2","ADENOSINE KINASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 106;SER M 101;LEU M  73;LEU M 235","None;3PE M 505 ( 3.8A);None;None","0.88A","4n09A-6g2jM:undetectable","4kqiA-6g2jL:10.14"],["4N09_B_ADNB401_2","ADENOSINE KINASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 106;SER M 101;LEU M  73;LEU M 235","None;3PE M 505 ( 3.8A);None;None","0.86A","4n09B-6g2jM:undetectable","4n09A-6g2jM:11.90"],["4N09_D_ADND401_2","ADENOSINE KINASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 106;SER M 101;LEU M  73;LEU M 235","None;3PE M 505 ( 3.8A);None;None","0.88A","4n09D-6g2jM:undetectable","4n09B-6g2jM:11.90"],["4P6S_A_DAHA305_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 253;HIS A 190;HIS A 343;ALA A 310"," ZN A 501 ( 3.5A); ZN A 502 (-3.5A); ZN A 502 ( 3.6A);3PE A 503 ( 4.7A)","0.70A","4p6sA-4qn9A:undetectable","4n09D-6g2jM:11.90"],["4P6S_A_DAHA305_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 343;HIS A 190;HIS A 253;ALA A 310"," ZN A 502 ( 3.6A); ZN A 502 (-3.5A); ZN A 501 ( 3.5A);3PE A 503 ( 4.7A)","0.93A","4p6sA-4qn9A:undetectable","4p6sA-4qn9A:22.02"],["4QN9_B_DXCB601_0","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"TYR A 188;TRP A 218;ARG A 257;THR A 258","3PE A 503 ( 4.9A);DXC A 504 ( 3.9A);None;DXC A 507 (-3.7A)","0.12A","4qn9A-4qn9A:61.9;4qn9B-4qn9A:60.5","4p6sA-4qn9A:22.02"],["4QN9_B_DXCB610_0","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",3,"GLY A 161;PRO A 162;ALA A 348","3PE A 503 ( 4.5A);3PE A 503 ( 4.7A);None","0.07A","4qn9B-4qn9A:60.5","4qn9A-4qn9A:100.00;4qn9B-4qn9A:100.00"],["4UDA_A_DEXA1985_1","MINERALOCORTICOID RECEPTOR","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"LEU M  68;ALA M 232;MET M 294;SER M 290;LEU M 315","3PE M 503 ( 4.2A);None;None;None;None","1.46A","4udaA-6g2jM:undetectable","4qn9B-4qn9A:100.00"],["4X1K_B_LOCB502_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"CYH M 199;LEU M 160;LEU M 195;ALA M 163;THR M 182","None;None;3PE M 502 ( 4.1A);3PE M 502 ( 4.3A);None","0.97A","4x1kA-6g2jM:undetectable;4x1kB-6g2jM:undetectable","4udaA-6g2jM:18.37"],["4X1Y_B_LOCB502_1","TUBULIN BETA CHAIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",5,"CYH M 199;LEU M 160;LEU M 195;ALA M 163;THR M 182","None;None;3PE M 502 ( 4.1A);3PE M 502 ( 4.3A);None","1.10A","4x1yB-6g2jM:undetectable","4x1kA-6g2jM:10.93;4x1kB-6g2jM:11.81"],["5B8I_C_FK5C201_1","SERINE\/THREONINE-PROTEIN PHOSPHATASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"LEU M 457;SER M  62;PRO M  64;PHE M 110","None;None;3PE M 503 ( 4.6A);None","1.14A","5b8iA-6g2jM:undetectable","4x1yB-6g2jM:11.81"],["5D4U_A_SAMA301_0","UNCHARACTERIZED PROTEIN MJ0489","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5","Mus musculus",5,"LEU L 216;MET L 314;LEU L 283;GLY L 228;GLY L 181","None;None;None;3PE L 701 (-3.9A);None","1.14A","5d4uA-6g2jL:undetectable","5b8iA-6g2jM:11.14"],["5I3A_A_HQEA303_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 253;HIS A 190;HIS A 343;ALA A 310"," ZN A 501 ( 3.5A); ZN A 502 (-3.5A); ZN A 502 ( 3.6A);3PE A 503 ( 4.7A)","0.73A","5i3aA-4qn9A:undetectable","5d4uA-6g2jL:undetectable"],["5I3A_A_HQEA303_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 343;HIS A 190;HIS A 253;ALA A 310"," ZN A 502 ( 3.6A); ZN A 502 (-3.5A); ZN A 501 ( 3.5A);3PE A 503 ( 4.7A)","0.88A","5i3aA-4qn9A:undetectable","5i3aA-4qn9A:22.02"],["5I3A_B_HQEB304_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 253;HIS A 190;HIS A 343;ALA A 310"," ZN A 501 ( 3.5A); ZN A 502 (-3.5A); ZN A 502 ( 3.6A);3PE A 503 ( 4.7A)","0.73A","5i3aB-4qn9A:undetectable","5i3aA-4qn9A:22.02"],["5I3A_B_HQEB304_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 343;HIS A 190;HIS A 253;ALA A 310"," ZN A 502 ( 3.6A); ZN A 502 (-3.5A); ZN A 501 ( 3.5A);3PE A 503 ( 4.7A)","0.86A","5i3aB-4qn9A:undetectable","5i3aB-4qn9A:22.02"],["5I3B_A_HQEA303_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 253;HIS A 190;HIS A 343;ALA A 310"," ZN A 501 ( 3.5A); ZN A 502 (-3.5A); ZN A 502 ( 3.6A);3PE A 503 ( 4.7A)","0.73A","5i3bA-4qn9A:undetectable","5i3aB-4qn9A:22.02"],["5I3B_A_HQEA303_1","TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"HIS A 343;HIS A 190;HIS A 253;ALA A 310"," ZN A 502 ( 3.6A); ZN A 502 (-3.5A); ZN A 501 ( 3.5A);3PE A 503 ( 4.7A)","0.87A","5i3bA-4qn9A:undetectable","5i3bA-4qn9A:22.02"],["5NCD_D_ACTD301_0","PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"ASP A 284;HIS A 190;HIS A 132;HIS A 321"," ZN A 502 (-2.5A); ZN A 502 (-3.5A);None;3PE A 503 (-3.8A)","1.31A","5ncdD-4qn9A:undetectable","5i3bA-4qn9A:22.02"],["5NEK_D_AZMD302_1","PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",4,"ASP A 284;HIS A 343;HIS A 321;HIS A 185"," ZN A 502 (-2.5A); ZN A 502 ( 3.6A);3PE A 503 (-3.8A); ZN A 501 (-3.6A)","0.91A","5nekD-4qn9A:undetectable","5ncdD-4qn9A:21.43"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",6,"HIS A 185;HIS A 187;HIS A 190;HIS A 253;ASP A 284;HIS A 321"," ZN A 501 (-3.6A); ZN A 501 ( 3.4A); ZN A 502 (-3.5A); ZN A 501 ( 3.5A); ZN A 502 (-2.5A);3PE A 503 (-3.8A)","0.34A","5nzwA-4qn9A:12.2","5nekD-4qn9A:12.21"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 253;HIS A 185;HIS A 321;ASP A 284;HIS A 343"," ZN A 501 ( 3.5A); ZN A 501 (-3.6A);3PE A 503 (-3.8A); ZN A 502 (-2.5A); ZN A 502 ( 3.6A)","1.02A","5nzwA-4qn9A:12.2","5nzwA-4qn9A:22.80"],["5Z0F_B_DAHB98_0","MELC;TYROSINASE","4qn9","N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D","Homo sapiens",5,"HIS A 190;HIS A 132;HIS A 321;ASP A 323;PRO A 324"," ZN A 502 (-3.5A);None;3PE A 503 (-3.8A);None;None","1.29A","5z0fA-4qn9A:undetectable;5z0fB-4qn9A:undetectable","5nzwA-4qn9A:22.80"],["6DWD_B_GLYB709_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","5lnk","MITOCHONDRIAL COMPLEX I, B14.5B SUBUNIT","Ovis aries",4,"GLY o  42;ASN o  46;ASP o  45;ARG o  60","None;None;None;3PE o 203 (-3.3A)","1.40A","6dwdB-5lnko:undetectable;6dwdD-5lnko:undetectable","5z0fA-4qn9A:13.05;5z0fB-4qn9A:10.69"],["6DWJ_B_GLYB710_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","5lnk","MITOCHONDRIAL COMPLEX I, B14.5B SUBUNIT","Ovis aries",4,"ARG o  60;GLY o  42;ASN o  46;ASP o  45","3PE o 203 (-3.3A);None;None;None","1.26A","6dwjB-5lnko:undetectable;6dwjD-5lnko:undetectable","6dwdB-5lnko:13.13;6dwdD-5lnko:13.13"],["6MVX_A_K4DA1304_0","ION TRANSPORT PROTEIN","6g2j","NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4","Mus musculus",4,"THR M  69;LEU M  68;MET M  76;LEU M  39","None;3PE M 503 ( 4.2A);None;None","1.05A","6mvxA-6g2jM:undetectable;6mvxB-6g2jM:undetectable;6mvxC-6g2jM:undetectable","6dwjB-5lnko:13.13;6dwjD-5lnko:13.13"]]